Physician profile
Waheed A Bhatti
NPI 1043490253
$695.88
in general payments reported to CMS, 2019-2025
13 companies · $52.52 in 2025
The $52.52 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.11 · 2020: $17.86 · 2021: $124 · 2022: $57.47 · 2023: $270 · 2024: $124 · 2025: $52.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $145.04 | 2020-2023 | Mounjaro |
| Atricure, INC. | $125.82 | 2023 | |
| Astellas Pharma US INC | $111.25 | 2023-2025 | Veozah |
| Abbott Laboratories | $83.64 | 2019-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $56.74 | 2023-2024 | Cologuard Collection Kit |
| Phadia US INC. | $33.46 | 2019-2024 | Immunocap |
| Edwards Lifesciences Corporation | $31.98 | 2024 | Sapien 3 Ultra Resilia |
| Amgen INC. | $31.27 | 2019-2024 | Otezla, Repatha |
| Gilead Sciences, INC. | $18.92 | 2021 | |
| Daiichi Sankyo INC. | $18.76 | 2021 | |
| Linus Health, INC. | $14.41 | 2023 | |
| Pfizer INC. | $12.77 | 2023 | |
| Janssen Pharmaceuticals, INC | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waheed Bhatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.